The European Life Sciences Web Portal
This is a free web portal for the life sciences in Europe and Israel... » read more
- Novartis Completes Divestiture of Influenza Vaccines to CSL (2015-08-03)
CSL Limited acquired influenza vaccines business of Novartis, including influenza vaccines development pipeline Novartis today announced that it has completed effective July 31, 2015 the divestiture of its influenza vaccine unit to CSL Limited. This marks t...
- Eurofins Closes Majority Acquisition of Bio-Access/Labazur (2015-08-03)
Eurofins Scientific (EUFI.PA), the global leader in bio-analytical testing, and one of the world leaders in genomic services, announces the successful closing of the transaction to acquire a controlling stake in Bio-Access, together with its founder Dr. Jean-Louis ...
- Thomas Bachmann Joins Eppendorf as CEO from Bruker (2015-08-03)
Thomas Bachmann became Chief Executive Officer of the Eppendorf Group on August 1, 2015. Following the departure of Eppendorf's previous CEO, the company's Chief Financial Officer, Detmar Ammermann, had exercised the function of Spokesman of the Management Board on...
- Santhera: Capital Increase to Finance LHON Launch of Raxone (2015-07-31)
Santhera Pharmaceuticals (SIX: SANN) announces the intent to sell up to 300,000 registered shares of newly created treasury shares (representing 6.03% of the company's total outstanding share capital). The proceeds will be used to finance the commercial launch of R...
- Merck Appoints Isabel De Paoli Head of Group Communications (2015-07-30)
> Walter Huber will retire on March 8, 2016, following 18 years as Head of Group Communications > Heiko Schön will take over as Head of Group Strategy on Aug. 1, 2015 Isabel De Paoli (40), currently Head of Group Strategy, has been appointed Head of Group C...
- Novartis, Phase4 Partners Create Mereo BioPharma Group Ltd (2015-07-29)
> Novartis is spinning off three mid stage clinical assets to Mereo for further development in exchange for equity > Novartis will have a stake in the success of the development of these compounds, including receiving payments on milestones and royalties on futu...
- Sophia Genetics Announces Partnership with Genycell Biotech (2015-07-29)
> Sophia Genetics and Genycell Biotech announce a game changing partnership in the Iberian Peninsula > 20 leading public Spanish and Portuguese healthcare client institutions of Genycell Biotech will benefit from Sophia Genetics’ advanced technology > The par...
- BRAIN AG Promotes Jürgen Eck to CEO Position (2015-07-29)
BRAIN AG announces its next steps concerning the expansion of the company’s industrialization strategy, “BRAIN Agenda 2020”, which has been approved by the management board, supervisory board, and shareholders alike. The steady commitment to this strategy had alrea...
- Pieris Closes $28.3m Public Offering after Over-allotment (2015-07-28)
Pieris Pharmaceuticals, Inc. (NASDAQ: PIRS), a biotechnology company advancing its proprietary Anticalin® biotherapeutic technologies, today announced that it closed the sale of an additional 1,211,827 shares of its common stock at the public offering price of $2.7...
- R-Biopharm to Develop CDx for Apogenix’ Lead Drug APG101 (2015-07-28)
Apogenix, a next generation immuno-oncology company, announced today that it has entered into an agreement with R-Biopharm, a global provider of innovative clinical diagnostics, to develop companion diagnostic tests for Apogenix’ lead drug candidate APG101. APG101 ...
Life-Sciences-Europe.com is your doorway to the European life sciences!
[LSE] provides free, up-to-date and structured access to
in Europe and Israel.
Access is unrestricted and free, requiring no log in and no user registration.The high-quality content is not related to the advertising, with topical relevance being the criterion for inclusion. [LSe] is 100% Made in Germany!Start here with the latest News!
To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to firstname.lastname@example.org and simply fill the subject line with the word »LSE newsletter«
To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]
Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)